CPT S4 - Diabetes Flashcards
Give some types of diabetes
Type I - >insulin deficiency >autoimmune or non-autoimmune Type II - >insulin deficiency & insulin resistance Genetic defects of beta cell Genetic defects of insulin action Drug-induced diabetes Associated with other hormone disorders
What treatments are available for type two diabetes?
Insulin sensitisers Beta cell stimulators Appetite suppressants Weight loss agents Urinary glucose eliminators Insulin
What diet and lifestyle advice can be given for diabetes?
Encourage complex carbohydrates Limit alcohol Limit salt Stop smoking Exercise Reduce overall energy intake if overweight
Name some types of non-insulin diabetes drugs
Biguanides Sulphonylureas Meglitinides Thiazolidinediones Alpha-glucosidase inhibitors Glucagon-like peptide 1 (GLP1) analogues Dipeptyl-peptidase 4 (DPP4) inhibitors Sodium glucose cotransporter 2 inhibitors
Give the actions and mechanism of action of biguanides?
Only one in use is metformin
Reduces insulin resistance by increasing insulin receptor sensitivity
Inhibits hepatic gluconeogenesis
Decreased glucose absorption from gut
Stimulates glucose uptake in muscle and adipose
Weight neutral
No action on islet cells
Give some contraindications for metformin
Do NOT give in cardiac, respiratory, renal or hepatic failure due to increased risk of lactic acidosis
Give some ADRs of metformin
High incidence of GI symptoms
May have slight weight gain
Describe the pharmacokinetic activity of metformin
4 hour half life
Not metabolised
Renal elimination
Give some examples of sulphonylureas
Gliclazide
Glimeprazide
Glipizide
What is the mechanism of action of sulphonylureas?
Stimulates beta cells, so requires some residual function
Specific receptor on beta cell
Give some ADRs for sulphonylureas
Hypoglycaemia, especially in the elderly, with missed meals or with excess alcohol
Weight gain
However, CAN be given in renal failure
Describe meglitinides
Eg repaglinide & nateglinide
Site of action is a K ATPase channel on beta cells
Distinct from sulphonylureas as different receptors, but similar pharmacological action
Shorter half life
More rapid action than sulphonylureas
Taken immediately before meals
Give the actions and mechanisms of actions of thiazolidinediones
Insulin sensitisers
Stimulate nuclear peroxisome proliferator activated receptor gamma
So regulate adipose, muscle and liver gene expression
Increased glucose utilisation
Decreased glucose production
Suppresses gluconeogenesis in liver
What are some problems with thiazolidinediones, aka glitazones
Pioglitazone only available agent Weight gain and oedema Contraindicated in heart failure Fractures in post menopausal women Bladder cancers Rarely used now
Describe DPP4 inhibitors
Aka gliptins
Increases postprandial active GLP1 concentrations
Side effects include GI symptoms and ?pancreatitis
Low hypoglycaemic risk
Weight neutral
Modest HbA1c reduction